Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2Bio) Gene Therapy (GT) Products

NCT06885424 is registered in ClinicalTrials.gov with A2 Biotherapeutics Inc. as lead sponsor.

NCT NCT06885424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06885424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2Bio) Gene Therapy (GT) Products
Lead sponsor
A2 Biotherapeutics Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
July 31, 2025
Completion date
March 31, 2040
Enrollment
400 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal carcinoma, colorectal carcinoma (crc), head and neck (hnscc), head and neck cancer, mesothelioma, non small cell lung cancer, nsclc, ovarian cancer, ovarian carcinoma, pancreatic cancer, renal cell carcinoma (kidney cancer), small cell lung cancer ( sclc ), solid tumor cancer, solid tumor, unspecified, adult, triple negative breast cancer (tnbc)